Intraperitoneal propofol and propofol fentanyl, sufentanil and remifentanil combinations for mouse anaesthesia.
The combination of propofol and a rapid-acting opioid, such as fentanyl, sufentanil or remifentanil, is a relatively safe, total intravenous anaesthesia technique, commonly used in humans and which has been investigated in laboratory animals. The objective of this study was to evaluate these combinations for anaesthesia of mice by the intraperitoneal (i.p.) route. Sixty-seven mice, divided into groups of four, were used to test 28 combinations of propofol alone and propofol with fentanyl, sufentanil or remifentanil administered i.p. The dose ranges of drugs studied were propofol 50-200 mg/kg, fentanyl 0.2-0.4 mg/kg, sufentanil 0.05-0.1 mg/kg and remifentanil 0.2-1.0 mg/kg. The loss of righting reflex (RR) and the loss of pedal withdrawal reflex (PWR) were recorded along with the duration and quality of recovery. The results obtained in these studies were unpredictable. The same dose combinations of propofol and opioids were associated with different responses in different individuals. Higher doses did not induce loss of RR and PWR in all animals and were associated with high mortality rates. An adequate hypnotic level was only observed with higher doses of propofol. The synergistic effect of propofol and the opioids was not sufficient to allow surgical procedures. Animals that reached PWR loss showed tail rigidity, shaking limbs and scratched their heads with their forefeet. Higher opioid doses induced respiratory depression and higher death rates. The inconsistency between and within groups may be associated with the i.p. route. The results reported here show that the i.p. route is not appropriate for mouse anaesthesia using propofol alone or in combination with fentanyl, sufentanil or remifentanil.
Alves
H C
HC
CECAV-UTAD, Centro de Estudos de Ciências Animais e Veterinárias, Universidade de Trás-os-Montes e Alto Douro, Vila Real, Portugal. heber.alves@sapo.pt
Valentim
A M
AM
Olsson
I A S
IA
Antunes
L M
LM
D000759:Adjuvants, Anesthesia; D000758:Anesthesia / Q000662:veterinary*; D019162:Anesthetics, Combined / Q000008:administration & dosage*; D000818:Animals; D004305:Dose-Response Relationship, Drug; D005283:Fentanyl / Q000008:administration & dosage*; D007274:Injections, Intraperitoneal / Q000662:veterinary; D007756:Laboratory Animal Science / Q000379:methods; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D010880:Piperidines / Q000008:administration & dosage*; D015742:Propofol / Q000008:administration & dosage*; D000077208:Remifentanil; D017409:Sufentanil / Q000008:administration & dosage*
D000759:Adjuvants, Anesthesia; D019162:Anesthetics, Combined; D010880:Piperidines; D017409:Sufentanil; D000077208:Remifentanil; D005283:Fentanyl; D015742:Propofol